L-651896

N/A

Report date: 2022/03/14 18:05:37
NME

Base Information

Drug NameL-651896
Drug Alias NameL-651896
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action5-lipoxygenase activating protein inhibitorsLeukotriene inhibitorsArachidonate 5-lipoxygenase inhibitors
TargetsArachidonate 5-lipoxygenaseLeukotriene5-lipoxygenase activating protein
Therapy Area/IndicationsRheumatic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme Corp
Active IndicationsN/A
Inactive IndicationsRheumatic Diseases

Other Information

ATC CodeN/A
Related LinksN/A